Assistant Professor of Dermatology
Dermatology
Dr. Sean R. Christensen, MD
|
|
Give Review
Sean Christensen works in the field of Dermatology. He attended Yale University School of Medicine. Yale University School of Medicine is a top medical university. Yale University School of Medicine is ranked 7/57 in Research/PrimaryCare. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Doctor Sean R. Christensen, MD is a published doctor. He published 15 publications, including: 'Histopathologic assessment of depth of follicular invasion of squamous cell carcinoma (SCC) in situ (SCCis): Implications for treatment approach.' He is registered with Medicare.
Publications
- Histopathologic assessment of depth of follicular invasion of squamous Cell carcinoma (SCC) in situ (SCCis): Implications for treatment approach.
- TLR9 Promotes Tolerance by Restricting Survival of Anergic Anti-DNA B Cells, Yet Is Also Required for Their Activation.
- Erythroderma and spontaneous blistering in a 49-year-old man.
- TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus.
- Differential cytokine production and bystander activation of autoreactive B Cells in response to CpG-A and CpG-B oligonucleotides.
- Murine B Cell response to TLR7 ligands depends on an IFN-beta feedback loop.
- Autoreactive B Cells discriminate CpG-rich and CpG-poor DNA and this response is modulated by IFN-alpha.
- T Cell-independent and toll-like receptor-dependent antigen-driven activation of autoreactive B Cells.
- Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.
- RNA-associated autoantigens activate B Cells by combined B Cell antigen receptor/Toll-like receptor 7 engagement.
- Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus.
- Bazex syndrome (acroKeratosis paraneoplastica).
- Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors.
- A new site-directed transgenic rheumatoid factor mouse model demonstrates extrafollicular class switch and plasmablast formation.
Schools
Yale Univ Sch Of Med
Procedures Preformed
- Adjacent Tissue Transfer
- Destruction of Malignant Skin Lesion
- Excision of Malignant Skin Lesion
- Mohs Surgery
Conditions Treated
- Actinic Keratosis
- Basal Cell Carcinoma
- Carcinoma in Situ of Skin
- Dermatitis
- View All
Doctors Specialties
- Dermatology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Yale-New Haven Hospital -
Yale University School of Medicine
Drug Facts
| NPI NUMBER | 1962685073 | |
| NPPES Provider LastName | CHRISTENSEN | |
| NPPES Provider FirstName | SEAN | |
| NPPES Provider ZIPCode | 065102715 | |
| NPPES Provider State | CT | |
| Specialty Description | Dermatology | |
| Total Claim Count | 67.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1962685073 |
| Last Name Of The Provider | CHRISTENSEN |
| First Name Of The Provider | SEAN |
| View All |
Similar Doctors
|
|
Dr. Richard J. Antaya, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Samuel E. Book, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sumaira Z. Aasi, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Jennifer M. McNiff, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|